# OptiBiotix Health plc Presentation of abstract at Probiotics for cholesterol reduction

- Link: https://www.directorstalkinterviews.com/optibiotix-health-plc-presentation-abstract-probiotics-cholesterol-reduction/412728219
- Published: 2017-05-03T07:11:32+01:00
- Author: Giles Arbor

**OptiBiotix Health plc** (LON:OPTI), a life sciences business developing compounds
to tackle obesity, high cholesterol, diabetes and skin care, announced today that
it has had an abstract accepted for presentation at the International Scientific
Conference on Probiotics and Prebiotics in Budapest, Hungary from 20 – 22 June 2017(
IPC2017). IPC2017 is the largest scientific conference worldwide focusing on probiotics
and prebiotics for scientists, researchers, product developers, industry and the
investment community. The conference attracts up to 500 leading scientists, opinion
leaders, investors, and clinicians from more than 80 countries.

The abstract, titled “The Development of a Targeted Synergistic Synbiotic for Lactobacillus
plantarum LPLDL®”, describes how by combining its OptiScreen® and OptiBiotic®, OptiBiotix
were able to synthesise a dietary fibre that substantially enhances the cholesterol
reducing activity of LPLDL® in gut models. This creates the potential for next generation
LPLDL® products with cholesterol reduction levels potentially approaching those 
of statins.

> **Commenting, Stephen O’Hara, CEO of OptiBiotix Health plc said:** “This abstract
> demonstrates the ability of OptiBiotix to create targeted prebiotics which when
> combined with a probiotic greatly enhances the probiotics growth and biological
> effect, in this case cholesterol reduction. This new research highlights the potential
> for the development of species or genera-specific probiotics to selectively enhance
> the growth and health benefits of existing probiotics. This has the potential 
> to provide improved next generation products with enhanced performance and product
> differentiation in the probiotics functional food market, a market that is expected
> to be worth in excess of $46.5bn by 2020.”

Share on:
